When Courts Can Approve Plea Bargains Over Prosecution Objection in Drug Cases

The Supreme Court recently clarified the boundaries of judicial discretion in approving plea bargaining agreements in drug cases, even when the prosecution objects. In People of the Philippines v. Rene Esma y Joven (G.R. No. 250979, January 11, 2023), the Court affirmed that trial courts may approve a plea bargain that conforms to the Court-issued framework, notwithstanding the prosecutor's refusal to consent. The ruling underscores the judiciary's exclusive power to promulgate rules of procedure and provides practical guidance for judges, prosecutors, and accused persons navigating plea bargaining under the Comprehensive Dangerous Drugs Act.

The Facts of the Case

Rene Esma was charged with illegal sale and illegal possession of shabu under Sections 5 and 11, Article II of Republic Act No. 9165. The quantities involved were minimal: 0.0416 grams for the sale charge and 0.0694 grams for the possession charge.

During trial, Esma moved to plead guilty to a lesser offense—possession of drug paraphernalia under Section 12, Article II of RA 9165. The prosecution opposed, citing Department of Justice (DOJ) Circular No. 27, which at the time provided that the acceptable plea bargain for illegal sale of less than five grams of shabu was a plea to illegal possession under Section 11, not Section 12.

The Regional Trial Court approved the plea bargain, subject to a drug dependency examination and rehabilitation. The Court of Appeals affirmed. The prosecution elevated the matter to the Supreme Court, arguing that its consent was indispensable and that the approval violated its right to procedural due process.

The Issue Presented

The central question was whether a trial court may approve a plea bargaining agreement over the objection of the prosecution, and whether the prosecution's consent is an absolute requirement under the Rules of Court.

The Supreme Court's Ruling

The Supreme Court denied the petition and affirmed the approval of the plea bargain. In doing so, the Court made several important pronouncements.

First, the Court took judicial notice of DOJ Circular No. 18 (May 10, 2022), which revoked DOJ Circular No. 27. Under the new circular, an accused charged with illegal sale of 0.01 to 0.99 grams of shabu may plead to the lesser offense of illegal possession of drug paraphernalia under Section 12—exactly what Esma proposed. This aligned with the Court's own Plea Bargaining Framework in A.M. No. 18-03-16-SC.

Second, the Court reiterated that plea bargaining in criminal cases is a rule of procedure that falls within the exclusive rule-making power of the Supreme Court under Section 5(5), Article VIII of the 1987 Constitution. This power is not shared with the executive or legislative departments. DOJ circulars, the Court explained, serve only as internal guidelines for prosecutors and cannot repeal, alter, or modify the Court-issued framework.

Third, the Court clarified the role of prosecutorial consent. Citing People v. Reafor (G.R. No. 247575, November 16, 2020), the Court held that while plea bargaining requires mutual agreement of the parties and remains subject to court approval, the prosecution's refusal to consent should be treated as a continuing objection that the trial court must resolve. The decision to sustain or overrule that objection rests on the trial court's sound discretion.

Fourth, the Court adopted clarificatory guidelines from the consolidated cases of People v. Montierro and related cases (July 26, 2022). These guidelines provide, among others, that:

• Plea bargaining proposals must be initiated by written motion of the accused.
• The lesser offense must be necessarily included in the offense charged.
• Judges may overrule prosecution objections based solely on inconsistency with internal DOJ guidelines, if the proposal conforms to the Court's framework.
• Courts must hear and rule on prosecution objections based on valid grounds, such as the accused being a recidivist or the evidence of guilt being strong.

Applying these principles, the Court found that Esma's plea bargain conformed to DOJ Circular No. 18, A.M. No. 18-03-16-SC, and the clarified guidelines. The prosecution's objection, based on an outdated DOJ circular, did not bar approval.

What This Means for Practitioners

The decision provides important guidance for criminal cases involving dangerous drugs. Trial courts retain discretion to approve plea bargains that conform to the Court's framework, even without prosecutorial consent. Prosecutors, for their part, must anchor their objections on valid grounds—not merely on internal DOJ guidelines that conflict with the Court's issuances.

For accused persons, the ruling confirms that a plea bargain is not a matter of right, but a properly crafted proposal that follows the Court's framework may be approved despite prosecutorial opposition.

Practical Takeaways

• Trial courts have the final say. Approval of a plea bargain rests on the sound discretion of the judge, guided by the Court's Plea Bargaining Framework in A.M. No. 18-03-16-SC.
• Prosecution consent is not absolute. A prosecutor's objection based solely on internal DOJ guidelines may be overruled if the proposal conforms to the Court's framework.
• DOJ circulars are internal guidelines. They cannot override or modify rules of procedure promulgated by the Supreme Court.
• Valid objections still matter. Courts must hear and rule on objections based on grounds like recidivism, strong evidence of guilt, or non-conformity with the framework.
• Drug dependency assessment is key. Approval of a plea bargain in drug cases typically requires a drug dependency examination and rehabilitation as conditions.

This article is general information and not legal advice. For your specific situation, consult a lawyer or ask ASG Legal AI.